vs
Tonix Pharmaceuticals Holding Corp.（TNXP）与Xos, Inc.（XOS）财务数据对比。点击上方公司名可切换其他公司
Tonix Pharmaceuticals Holding Corp.的季度营收约是Xos, Inc.的1.0倍（$5.4M vs $5.2M），Xos, Inc.净利率更高（-186.8% vs -870.3%，领先683.5%），Tonix Pharmaceuticals Holding Corp.同比增速更快（108.8% vs -54.5%），过去两年Tonix Pharmaceuticals Holding Corp.的营收复合增速更高（47.4% vs -35.7%）
Tonix Pharmaceuticals是一家总部位于美国新泽西州查塔姆的制药企业，核心业务聚焦于中枢神经系统疾病适应症的再利用药物开发，截至2020年，该公司同时还在开展新冠疫苗研发以及一个生物防御相关项目。
Xos, Inc.是一家美国制造商，专注于生产商用电动车辆以及移动式电动汽车充电桩。该公司扎根商用车电动化领域，为物流、货运等商业运输场景提供纯电动力解决方案与配套充电设备，助力商用车领域的低碳转型。
TNXP vs XOS — 直观对比
营收规模更大
TNXP
是对方的1.0倍
$5.2M
营收增速更快
TNXP
高出163.3%
-54.5%
净利率更高
XOS
高出683.5%
-870.3%
两年增速更快
TNXP
近两年复合增速
-35.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $5.4M | $5.2M |
| 净利润 | $-46.9M | $-9.8M |
| 毛利率 | 80.4% | -50.5% |
| 营业利润率 | -895.8% | -186.6% |
| 净利率 | -870.3% | -186.8% |
| 营收同比 | 108.8% | -54.5% |
| 净利润同比 | -112.2% | 48.6% |
| 每股收益（稀释后） | $-4.28 | $-0.76 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收TNXPXOS
| Q4 25 | $5.4M | $5.2M | ||
| Q3 25 | $3.3M | $16.5M | ||
| Q2 25 | $2.0M | $18.4M | ||
| Q1 25 | $2.4M | $5.9M | ||
| Q4 24 | $2.6M | $11.5M | ||
| Q3 24 | $2.8M | $15.8M | ||
| Q2 24 | $2.2M | $15.5M | ||
| Q1 24 | $2.5M | $12.6M |
净利润TNXPXOS
| Q4 25 | $-46.9M | $-9.8M | ||
| Q3 25 | $-32.0M | $2.1M | ||
| Q2 25 | $-28.3M | $-7.5M | ||
| Q1 25 | $-16.8M | $-10.2M | ||
| Q4 24 | $-22.1M | $-19.0M | ||
| Q3 24 | $-14.2M | $-10.5M | ||
| Q2 24 | $-78.8M | $-9.7M | ||
| Q1 24 | $-14.9M | $-11.0M |
毛利率TNXPXOS
| Q4 25 | 80.4% | -50.5% | ||
| Q3 25 | 58.4% | 15.3% | ||
| Q2 25 | -63.8% | 8.8% | ||
| Q1 25 | 61.2% | 20.6% | ||
| Q4 24 | 54.2% | -32.4% | ||
| Q3 24 | 44.9% | 18.1% | ||
| Q2 24 | -52.5% | 13.1% | ||
| Q1 24 | 33.1% | 22.1% |
营业利润率TNXPXOS
| Q4 25 | -895.8% | -186.6% | ||
| Q3 25 | -1005.1% | -42.4% | ||
| Q2 25 | -1416.2% | -38.5% | ||
| Q1 25 | -660.9% | -157.7% | ||
| Q4 24 | -870.6% | -127.0% | ||
| Q3 24 | -551.2% | -61.4% | ||
| Q2 24 | -3501.6% | -73.2% | ||
| Q1 24 | -860.2% | -81.1% |
净利率TNXPXOS
| Q4 25 | -870.3% | -186.8% | ||
| Q3 25 | -972.9% | 12.9% | ||
| Q2 25 | -1415.0% | -40.8% | ||
| Q1 25 | -692.8% | -173.3% | ||
| Q4 24 | -856.2% | -165.4% | ||
| Q3 24 | -503.6% | -66.6% | ||
| Q2 24 | -3567.8% | -62.2% | ||
| Q1 24 | -601.9% | -87.1% |
每股收益（稀释后）TNXPXOS
| Q4 25 | $-4.28 | $-0.76 | ||
| Q3 25 | $-3.59 | $0.22 | ||
| Q2 25 | $-3.86 | $-0.91 | ||
| Q1 25 | $-2.84 | $-1.26 | ||
| Q4 24 | $2302.65 | $-2.34 | ||
| Q3 24 | $-22.68 | $-1.32 | ||
| Q2 24 | $-1920.85 | $-1.23 | ||
| Q1 24 | $-535.72 | $-1.80 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $207.6M | $14.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $245.2M | $23.3M |
| 总资产 | $277.2M | $60.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资TNXPXOS
| Q4 25 | $207.6M | $14.0M | ||
| Q3 25 | $190.1M | $14.1M | ||
| Q2 25 | $125.3M | $8.8M | ||
| Q1 25 | $131.7M | $4.8M | ||
| Q4 24 | $98.8M | $11.0M | ||
| Q3 24 | $28.2M | $8.4M | ||
| Q2 24 | $4.2M | $19.7M | ||
| Q1 24 | $7.0M | $46.2M |
总债务TNXPXOS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $8.7M | — | ||
| Q3 24 | $9.4M | — | ||
| Q2 24 | $10.1M | — | ||
| Q1 24 | $10.8M | — |
股东权益TNXPXOS
| Q4 25 | $245.2M | $23.3M | ||
| Q3 25 | $231.1M | $31.1M | ||
| Q2 25 | $168.0M | $18.3M | ||
| Q1 25 | $180.4M | $24.8M | ||
| Q4 24 | $139.6M | $33.6M | ||
| Q3 24 | $74.2M | $50.8M | ||
| Q2 24 | $42.1M | $59.2M | ||
| Q1 24 | $108.1M | $67.8M |
总资产TNXPXOS
| Q4 25 | $277.2M | $60.4M | ||
| Q3 25 | $252.4M | $73.8M | ||
| Q2 25 | $187.4M | $80.3M | ||
| Q1 25 | $192.9M | $87.7M | ||
| Q4 24 | $162.9M | $98.3M | ||
| Q3 24 | $95.0M | $120.5M | ||
| Q2 24 | $70.3M | $123.4M | ||
| Q1 24 | $135.3M | $135.0M |
负债/权益比TNXPXOS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.06× | — | ||
| Q3 24 | 0.13× | — | ||
| Q2 24 | 0.24× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-39.6M | $2.4M |
| 自由现金流经营现金流 - 资本支出 | $-41.5M | — |
| 自由现金流率自由现金流/营收 | -770.4% | — |
| 资本支出强度资本支出/营收 | 34.8% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-103.2M | — |
8季度趋势，按日历期对齐
经营现金流TNXPXOS
| Q4 25 | $-39.6M | $2.4M | ||
| Q3 25 | $-28.8M | $3.1M | ||
| Q2 25 | $-14.8M | $4.6M | ||
| Q1 25 | $-16.6M | $-4.8M | ||
| Q4 24 | $-14.6M | $3.3M | ||
| Q3 24 | $-18.8M | $-11.5M | ||
| Q2 24 | $-9.9M | $-26.0M | ||
| Q1 24 | $-17.6M | $-14.6M |
自由现金流TNXPXOS
| Q4 25 | $-41.5M | — | ||
| Q3 25 | $-29.7M | — | ||
| Q2 25 | $-15.4M | — | ||
| Q1 25 | $-16.6M | — | ||
| Q4 24 | $-14.6M | — | ||
| Q3 24 | $-18.8M | $-11.7M | ||
| Q2 24 | — | $-26.1M | ||
| Q1 24 | $-17.7M | $-14.6M |
自由现金流率TNXPXOS
| Q4 25 | -770.4% | — | ||
| Q3 25 | -904.1% | — | ||
| Q2 25 | -768.8% | — | ||
| Q1 25 | -682.8% | — | ||
| Q4 24 | -566.7% | — | ||
| Q3 24 | -666.5% | -73.9% | ||
| Q2 24 | — | -168.1% | ||
| Q1 24 | -712.4% | -115.7% |
资本支出强度TNXPXOS
| Q4 25 | 34.8% | 0.0% | ||
| Q3 25 | 29.2% | 0.0% | ||
| Q2 25 | 26.4% | 0.0% | ||
| Q1 25 | 0.2% | 0.0% | ||
| Q4 24 | 0.1% | 0.0% | ||
| Q3 24 | 0.3% | 0.9% | ||
| Q2 24 | 0.0% | 0.8% | ||
| Q1 24 | 4.4% | 0.2% |
现金转化率TNXPXOS
| Q4 25 | — | — | ||
| Q3 25 | — | 1.45× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
TNXP
| Zembrace Symtouch | $3.1M | 58% |
| Other | $2.3M | 42% |
XOS
暂无分部数据
